Alcohol, Tobacco and Other Drug Research Unit, South African Medical Research Council, Cape Town, South Africa.
Department of Psychiatry, University of Stellenbosch, Cape Town, South Africa.
Addiction. 2023 Nov;118(11):2164-2176. doi: 10.1111/add.16278. Epub 2023 Jun 20.
Reduction of alcohol consumption is important for people undergoing treatment for HIV. We tested the efficacy of a brief intervention for reducing the average volume of alcohol consumed among patients on HIV antiretroviral therapy (ART).
DESIGN, SETTING AND PARTICIPANTS: This study used a two-arm multi-centre randomized controlled trial with follow-up to 6 months. Recruitment occurred between May 2016 and October 2017 at six ART clinics at public hospitals in Tshwane, South Africa. Participants were people living with HIV, mean age 40.8 years [standard deviation (SD) = 9.07], 57.5% female, and on average 6.9 years (SD = 3.62) on ART. At baseline (BL), the mean number of drinks consumed over the past 30 days was 25.2 (SD = 38.3). Of 756 eligible patients, 623 were enrolled.
Participants were randomly assigned to a motivational interviewing (MI)/problem-solving therapy (PST) intervention arm (four modules of MI and PST delivered over two sessions by interventionists) or a treatment as usual (TAU) comparison arm. People assessing outcomes were masked to group assignment.
The primary outcome was the number of standard drinks (15 ml pure alcohol) consumed during the past 30 days assessed at 6-month follow-up (6MFU).
Of the 305 participants randomized to MI/PST, 225 (74%) completed the intervention (all modules). At 6MFU, retention was 88% for the control and 83% for the intervention arm. In support of the hypothesis, an intention-to-treat-analysis for the primary outcome at 6MFU was -0.410 (95% confidence interval = -0.670 to -0.149) units lower on log scale in the intervention group than in the control group (P = 0.002), a 34% relative reduction in the number of drinks. Sensitivity analyses were undertaken for patients who had alcohol use disorders identification test (AUDIT) scores ≥ 8 at BL (n = 299). Findings were similar to those of the whole sample.
In South Africa, a motivational interviewing/problem-solving therapy intervention significantly reduced drinking levels in HIV-infected patients on antiretroviral therapy at 6-month follow-up.
减少饮酒量对正在接受 HIV 治疗的人群很重要。我们测试了一种简短干预措施的效果,该措施旨在减少接受 HIV 抗逆转录病毒治疗 (ART) 的患者的平均饮酒量。
设计、地点和参与者:这项研究采用了双臂、多中心、随机对照试验,随访时间为 6 个月。招募工作于 2016 年 5 月至 2017 年 10 月在南非茨瓦内六家公立医院的六家 ART 诊所进行。参与者为感染 HIV 的人群,平均年龄为 40.8 岁[标准差 (SD)=9.07],57.5%为女性,平均接受 ART 治疗 6.9 年[SD=3.62]。在基线 (BL) 时,过去 30 天内平均饮酒量为 25.2(SD=38.3)个标准饮品。在 756 名符合条件的患者中,有 623 名患者入组。
参与者被随机分配到动机性访谈 (MI)/问题解决治疗 (PST) 干预组(由干预者在两次会议上提供四个 MI 和 PST 模块)或常规治疗 (TAU) 对照组。评估结果的人员对分组情况不知情。
主要结局是在 6 个月随访时(6MFU)评估的过去 30 天内消耗的标准饮品数量(15ml 纯酒精)。
在被随机分配到 MI/PST 的 305 名参与者中,有 225 名(74%)完成了干预(所有模块)。在 6MFU 时,对照组的保留率为 88%,干预组的保留率为 83%。支持假设的意向治疗分析表明,在 6MFU 时,干预组的主要结局(log 尺度)比对照组低-0.410(95%置信区间=-0.670 至-0.149),表明在干预组中,饮酒量减少了 34%。对基线时酒精使用障碍识别测试(AUDIT)评分≥8 的患者(n=299)进行了敏感性分析。结果与全样本相似。
在南非,动机性访谈/问题解决治疗干预措施在 6 个月随访时显著降低了接受抗逆转录病毒治疗的 HIV 感染患者的饮酒水平。